|
NKRF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.256400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.447800E-01 |
| Normal-vs-Stage2 |
3.904600E-01 |
| Normal-vs-Stage3 |
3.804000E-01 |
| Normal-vs-Stage4 |
7.582400E-01 |
| Stage1-vs-Stage2 |
2.180800E-01 |
| Stage1-vs-Stage3 |
1.505160E-01 |
| Stage1-vs-Stage4 |
5.579400E-01 |
| Stage2-vs-Stage3 |
8.385800E-01 |
| Stage2-vs-Stage4 |
5.938200E-01 |
| Stage3-vs-Stage4 |
6.348000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.079000E-01 |
| Normal-vs-AfricanAmerican |
8.498400E-01 |
| Normal-vs-Asian |
2.293200E-01 |
| Caucasian-vs-AfricanAmerican |
6.580800E-01 |
| Caucasian-vs-Asian |
8.497600E-02 |
| AfricanAmerican-vs-Asian |
5.026800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.681000E-01 |
| Normal-vs-Female |
8.742800E-01 |
| Male-vs-Female |
8.195400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.515000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.380000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.011350E-01 |
| Normal-vs-Age(81-100Yrs) |
3.880000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.015850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.480900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.047000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.415840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.137200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.929600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.995010E-01 |
| Classical-VS-Follicular |
6.881700E-03 |
| Classical-VS-Other |
3.854200E-01 |
| Classical-VS-Normal |
4.651800E-01 |
| Tall-VS-Follicular |
5.878800E-01 |
| Tall-VS-Other |
8.171200E-01 |
| Tall-VS-Normal |
4.853600E-01 |
| Follicular-VS-Other |
9.576400E-01 |
| Follicular-VS-Normal |
1.724850E-01 |
| Other-VS-Normal |
5.323000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.758800E-01 |
| Normal-vs-N1 |
5.132000E-01 |
| N0-vs-N1 |
9.991200E-01 |
|
|
